Healthcare

Breast cancer deaths disproportionately affect women in low- and middle-income countries. However, healthtech innovations are increasingly making life-saving screening more accessible.

Keynote speaker Sarah de Lagarde will discuss the impact of healthtech at this year’s Impact Investor Conference. But before that, Sarah, a double amputee, will be attempting to climb Kilimanjaro and raise funds for STAND.

The investment by the alternative business unit of AXA Investment Managers will help healthtech startup Novocuff fund a key clinical trial in the US.

The Swedish impact investor’s inaugural venture fund was backed by European institutional investors and will back companies developing solutions to address future health and environmental challenges.

Impact Expansion has raised €150m for Impact Expansion Fund I and announced the fund’s first investment in Belgium into sustainable energy solutions provider BeliVert.

A report from Better Society Capital shows how the use of outcomes contracts is spreading in the UK, and quantifies their benefits in tackling social and health problems.

The Dutch healthtech venture builder will use the funds to bring more potentially groundbreaking healthcare innovations to market.

Kelix Bio, an emerging market biopharmaceutical platform, has been wholly acquired by Abu Dhabi investor Mubadala Investment Company.

NLC Health Ventures has raised €58m since 2023, including €14m this year, to invest in bringing innovations to market that will relieve mounting pressures on healthcare systems globally, it says.

Fund IV has received backing from a range of institutional investors, DFIs and philanthropies. It will invest in rapidly scaling financial services and healthcare businesses in global growth markets in Africa and Asia.